Mattia Boeri

Publications

• Establishment of Patient Derived Xenografts As Functional Testing of Lung Cancer Aggressiveness
  Scientific Reports. Jul, 2017  |   Pubmed ID: 28751748
• Baseline and Postoperative C-reactive Protein Levels Predict Mortality in Operable Lung Cancer
  European Journal of Cancer (Oxford, England : 1990). Jul, 2017  |   Pubmed ID: 28472743
• Inflammatory Status and Lung Function Predict Mortality in Lung Cancer Screening Participants
  European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP). Mar, 2017  |   Pubmed ID: 28333763
• Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers
  Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Jun, 2017  |   Pubmed ID: 28302568
• MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma MiRNA Signature
  Microarrays (Basel, Switzerland). Jul, 2016  |   Pubmed ID: 27600084
• [Lung Cancer Screening in High-risk Subjects: Early Detection with LDCT and Risk Stratification Using MiRNA-based Blood Test]
  Epidemiologia E Prevenzione. Jan-Feb, 2016  |   Pubmed ID: 26951732
• Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening Participants
  Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. May, 2016  |   Pubmed ID: 26921675
• Circulating MicroRNA Signature As Liquid-biopsy to Monitor Lung Cancer in Low-dose Computed Tomography Screening
  Oncotarget. Oct, 2015  |   Pubmed ID: 26451608
• Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk Populations
  EBioMedicine. Aug, 2015  |   Pubmed ID: 26425689
• Recent Advances of MicroRNA-based Molecular Diagnostics to Reduce False-positive Lung Cancer Imaging
  Expert Review of Molecular Diagnostics. Jun, 2015  |   Pubmed ID: 25924864
• Corrigendum to 'Biomolecular and Clinical Practice in Malignant Pleural Mesothelioma and Lung Cancer: What Thoracic Surgeons Should Know'
  European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery. Jan, 2015  |   Pubmed ID: 25694655
• Potential Biomarkers for Lung Cancer Screening
  Translational Lung Cancer Research. Jun, 2014  |   Pubmed ID: 25806293
• Therapeutic Use of MicroRNAs in Lung Cancer
  BioMed Research International. 2014  |   Pubmed ID: 25309923
• YAP1 Acts As Oncogenic Target of 11q22 Amplification in Multiple Cancer Subtypes
  Oncotarget. May, 2014  |   Pubmed ID: 24810989
• DRAGO (KIAA0247), a New DNA Damage-responsive, P53-inducible Gene That Cooperates with P53 As Oncosuppressor. [Corrected]
  Journal of the National Cancer Institute. Apr, 2014  |   Pubmed ID: 24652652
• Biomolecular and Clinical Practice in Malignant Pleural Mesothelioma and Lung Cancer: What Thoracic Surgeons Should Know
  European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery. Oct, 2014  |   Pubmed ID: 24623168
• Assessment of Circulating MicroRNAs in Plasma of Lung Cancer Patients
  Molecules (Basel, Switzerland). Mar, 2014  |   Pubmed ID: 24619302
• Clinical Utility of a Plasma-based MiRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: a Correlative MILD Trial Study
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Mar, 2014  |   Pubmed ID: 24419137
• Role of MicroRNAs in Lung Cancer: MicroRNA Signatures in Cancer Prognosis
  Cancer Journal (Sudbury, Mass.). May-Jun, 2012  |   Pubmed ID: 22647364
• MicroRNA Signatures in Tissues and Plasma Predict Development and Prognosis of Computed Tomography Detected Lung Cancer
  Proceedings of the National Academy of Sciences of the United States of America. Mar, 2011  |   Pubmed ID: 21300873
• Prognostic Determinants in Epithelioid Sarcoma
  European Journal of Cancer (Oxford, England : 1990). Jan, 2011  |   Pubmed ID: 20932739